AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01648894 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery after 11 weeks of delay after chemoradiotherapy.
Description: Surgery consists carcinological resection of the rectal cancer with total excision of the mesorectum after 11 weeks of delay after the end of chemoradiotherapy.
Study NCT01648894 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery after 7 weeks of delay after chemoradiotherapy
Description: Surgery consists carcinological resection of the rectal cancer with total excision of the mesorectum after 7 weeks of delay after the end of chemoradiotherapy
Study NCT00445523 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TroVax® (Immunological Vaccine Therapy)
Description: 16 Intramuscular injections of TroVax® over 47 weeks
Study NCT00445523 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon-alpha
Description: 36 subcutaneous IFN-α injections for 12 weeks. sc injection three times per week (5MU each)
Study NCT01561495 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Proton Therapy
Study NCT02780050 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core muscle activation using physical fitness
Description: 2 instructors, they had physical therapy (PT) certificate, take an exam for subject's muscle strength of each muscle. After that time, subjects take a rest for 10 minutes. Researchers educate to subjects for high quality CPR including 5 to 6cm compression depth, 100 to 120 beat per minute (bpm) rate, complete chest recoil. Subjects perform chest compression to manikin with skill reporting system during 4min under guidance of 110 bpm metronome sound (first chest compression). After 1st chest compression, subjects take a rest during an hour and carry out PT. PT consist of 30 second plank for 3 sets, 12 times bridge for 3 sets and 20 times leg extension for 3 sets. Subjects take a rest during 30 seconds between sets, 1 minute every 3 sets.~After PT completion, subjects take a rest during 10 minutes, and then perform 2nd chest compression in the same way of 1st chest compression. Researchers record subject's chest compression depth and rate in 1st and 2nd chest compression.
Study NCT01827579 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD25/71 allodepleted donor T-cells
Description: CD25/71 allodepleted donor T-cells will be administered at a dose of 10\^5 /kg at day 30 post-SCT, 3 x 10\^5 /kg at day 60 and 10\^6 /kg at day 90 post transplant
Study NCT02374398 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic Acid
Description: see arm/group descriptions
Study NCT02374398 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Aquamantys System
Description: see arm/group descriptions
Study NCT02374398 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Standard Electro-cautery and Saline
Study NCT03914404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: γ-linoleic acid and placebo(Thioctic Acid)
Description: * γ-linoleic acid (Evoprim soft capsule) twice a day and 4 capsules at a time.~* Thioctic Acid(LipoA HR Tab. 600mg) placebo once a day and 1 tablet at a time.
Study NCT03914404 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thioctic Acid and placebo(γ-linoleic acid)
Description: * Thioctic Acid(LipoA HR Tab. 600mg) once a day and 1 tablet at a time.~* γ-linoleic acid (Evoprim soft capsule) placebo twice a day and 4 capsules at a time.
Study NCT02180620 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No exercise
Description: During the no exercise trial (NoEX), the participants will remain sedentary during testing.
Study NCT02180620 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meal then exercise
Description: During the post-meal exercise trial (M→EX), 45 min of resistance training will be performed
Study NCT02180620 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise then meal
Description: During the exercise prior to the meal trial (EX→M), 45 min of resistance training will be performed
Study NCT02277977 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Contrast enhanced ultrasound
Description: Contrat enhanced ultrasound during septic shock
Study NCT00247741 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: spinal administration of articaine
Study NCT00247741 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: spinal administration of lidocaine
Study NCT05558306 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgery of distal radius fracture
Description: Surgery of distal radius fracture for displaced fractures
Study NCT05558306 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Reduction and cast treatment of distal radius fracture
Description: Reduction and cast treatment of distal radius fracture for minimally displaced fractures
Study NCT02146599 — intervention group
Intervention type: OTHER
Intervention: Administration of patient self-assessment
Study NCT02371122 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Therapy Setting 1 (Medtronic)
Description: RestoreSensor or RestoreUltra Setting 1
Study NCT02371122 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Therapy Setting 2 (Medtronic)
Description: Medtronic RestoreSensor or RestoreUltra Setting 2
Study NCT02371122 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Therapy Setting 3 (Medtronic)
Description: Medtronic RestoreSensor or RestoreUltra Setting 3
Study NCT02371122 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Therapy Setting 4 (Medtronic)
Description: Medtronic RestoreSensor or RestoreUltra Setting 4
Study NCT01748942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given IV
Study NCT01748942 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Given IV
Study NCT01748942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given PO
Study NCT01748942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Given PO
Study NCT01748942 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT01748942 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT01748942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT00637975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxycodone
Description: Arm A - 20 mg/day~Arm B - increasing dose startnig at 20 mg/day~For 15 days or until unacceptable toxicity develops.
Study NCT00637975 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oxycodone
Description: Arm A - 20 mg/day~Arm B - increasing dose startnig at 20 mg/day~For 15 days or until unacceptable toxicity develops.
Study NCT01748942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT01748942 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transoral Robotic Surgery
Description: Undergo TORS
Study NCT01748942 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transoral Robotic Surgery
Description: Undergo TORS
Study NCT04401748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Tablet: Oral
Study NCT04401748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Subcutaneous (SC) or Intravenous (IV) injection
Study NCT04401748 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azacitidine
Description: Subcutaneous (SC) or Intravenous (IV) injection
Study NCT04401748 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Tablet; Oral
Study NCT00255762 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: Given IV
Study NCT00255762 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: Given IV
Study NCT00255762 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bevacizumab
Description: Given IV
Study NCT00255762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT01236664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Memory training
Description: The Memory at Work program is a 4-hour classroom-based workshop that is led by a professional trainer. The format of the program is experiential, with a heavy focus on discussion, self-discovery, and hands-on use of trained skills. Specific memory compensation techniques are trained. Training consists of an explanation of each technique (i.e., how and when to use it, the science behind the technique) and ample opportunities for hands-on use of the strategies.
Study NCT01236664 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Workshop
Description: The control workshop consists of a 4-hour program that will train techniques for successfully completing Sudoku, word, and logic puzzles. Like the experimental intervention, the control workshop will be engaging and challenging, and will involve a combination of individual and group activities.
Study NCT00077051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Study NCT00077051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytochlor
Study NCT00077051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tetrahydrouridine
Study NCT00077051 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Study NCT02937025 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Left Atrial Appendage Occulder of Shanghai Push Medical Device Technology CO.td
Description: Implanting the Occluder to close the left atrial appendage
Study NCT00932984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LACTIC ACID(ND)
Description: Dermacyd Silver Floral (Lactic Acid) sample will be applied like a curative during 5 weeks (treatment period).
Study NCT00053703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Risperidone
Description: oral risperidone 0.5mg to 6mg daily for up to 52 weeks
Study NCT00053703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olanzapine (enrollment closed in this treatment)
Description: oral olanzapine 5-20mg per day for up to 52 weeks
Study NCT00053703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Molindone
Description: oral molindone from 10-140mg/daily for up to 52 weeks
Study NCT04820374 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pupil's light and pupil diameter
Description: It is necessary to meet the requirement that the pupil's light reflection is slightly restored to the state of entering the room, and then the tube is extubated and the pupil diameter and the light reflection are restored to the state of entering the room, leaving the recovery room
Study NCT04510688 — intervention group
Intervention type: DRUG
Intervention: Cabozantinib
Description: Observation of treatment with Cabozantinib
Study NCT03044886 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: vitamin D
Description: Subjects took vitamin D or placebo
Study NCT03044886 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: vitamin D
Description: Subjects took vitamin D or placebo
Study NCT03626584 — intervention group
Intervention type: OTHER
Intervention: 18F-NaF PET
Description: Hybrid 18F-NaF PET/MR imaging for observational diagnostic purposes
Study NCT00703053 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: A/Vietnam/1203/04
Description: Inactivated subvirion influenza rg A/Vietnam/1203/04 (clade 1) x PR8 A/H5N1 vaccine; dosages 45 mcg and 90 mcg.
Study NCT00703053 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: A/Indonesia/05/05
Description: Inactivated subvirion influenza rg A/Indonesia/05/05 (clade 2) x PR8 A/H5N1 vaccine; dosages 45 mcg and 90 mcg.
Study NCT04452903 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: communication skills
Description: 3-hour communication skill workshop, followed by a month-long period to assimilate and implement the new set of skills, with supervision available by phone from the trainers.
Study NCT03208751 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Exercise training
Description: Exercise intervention was divided into 3 phases:~Phase 1: 6 weeks of moderate continuous training (MCT) 20 to 40 minutes at intensity of 60% of VO2peak, 3 times/week Phase 2: 6 weeks of moderate intensity interval training (MIIT) 30-40 min, intensity 60 to 80% of VO2peak, twice weekly plus at least once weekly MCT home based training Phase 3 (after performing new exercise testing to adapt training intensities): 12 weeks of MIIT 40 min once/week, intensity 60-80/85% of VO2peak, plus at least twice weekly home based MCT. From phase 2, supervised sessions included resistance training of at least 3 muscle groups, 3x15 repetitions at moderate intensity (Borg 12-14).~Nutritional counseling is offered up to 4 times in 6 months on an individual basis.
Study NCT02903082 — intervention group
Intervention type: BIOLOGICAL
Intervention: Residue of blood further to NFS
Study NCT02903082 — intervention group
Intervention type: BIOLOGICAL
Intervention: Residue of blood further to preoperative workup
Study NCT02903082 — intervention group
Intervention type: BIOLOGICAL
Intervention: Bone marrow collected during a myelogram carried out for hematological pathology workup
Study NCT02903082 — intervention group
Intervention type: BIOLOGICAL
Intervention: Bone marrow collected during myelogram routinely performed during hospitalization in ICU
Study NCT03920722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 1 gram IV on Day 1 and 15 after premedication with 100 mg méthylprednisolone, 1 gramm paracetamol and 5 mg dexchlorpheniramine
Study NCT03920722 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo-Rituximab 1 gram IV on Day 1 and 15 after premedication with 100 mg méthylprednisolone, 1 gramm paracetamol and 5 mg dexchlorpheniramine
Study NCT03715153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BUMETANIDE (S95008) for week 0 - 26
Description: Oral solution dosed at 0.5 mg/mL Taken twice daily.
Study NCT03715153 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO for week 0 - 26
Description: Oral solution Taken twice daily.
Study NCT03715153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Open-Label BUMETANIDE (S95008) for weeks 26 - 52
Description: Oral solution dosed at 0.5 mg/mL Taken twice daily.
Study NCT03715153 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Open-Label BUMETANIDE (S95008) for weeks 26 - 52
Description: Oral solution dosed at 0.5 mg/mL Taken twice daily.
Study NCT02779738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Merestinib
Description: Administered orally
Study NCT00433342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flucloxacillin
Description: 500 mg QD oral
Study NCT01770912 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lactated Ringers
Description: Solution used for TMJ arthrocentesis procedure. 1 cc of Lactated Ringers solution injected once after the TMJ rinsing procedure.
Study NCT01770912 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone hexacetonide
Description: 1 cc of triamcinolone hexacetonide (5 mg) injected once after the TMJ rinsing procedure.
Study NCT01708291 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness based stress reduction
Description: an 8 week group intervention to teach mindfulness skills
Study NCT01708291 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: only pre and post evaluation measures
Study NCT02176187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berodual® Respimat® inhaler
Description: fenoterol hydrobromide 50μg + ipratropium bromide 20μg
Study NCT02176187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berodual® metered dose inhaler
Description: fenoterol hydrobromide 50μg + ipratropium bromide 20μg
Study NCT06235840 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: working memory adaptive training
Description: The computerized n-back training lasted 4 weeks and consisted of 12 training sessions, 3 per week, about 45 minutes for each
Study NCT06235840 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: multi-domain non-adaptive control training
Description: The cognitive training in active control groups included cognitive tasks involving: visual-spatial functions, visual and verbal memory, reasoning on visual and verbal material, and calculia. The training schedule in active control groups was the same as in the experimental groups.
Study NCT02798822 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rapid maxillary expansion
Description: When rapid maxillary expander was in-situ, patients waited 7 days before starting the screw activation of one quarter turn a day (0.22 mm) until overcorrection. Expansion was considered adequate when the occlusal surface of the first maxillary palatal cusp contacted the occlusal surface of the mandibular first molar facial cusp. When was achieved, rapid maxillary expander stayed in place for 10 months.
Study NCT03228069 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blood drawn after rabies booster vaccination
Description: Blood would be drawn for testing of rabies neutralizing antibody titers, rabies specific T lymphocytes and regulatory T cells after receipt of rabies booster vaccination at least a year before.
Study NCT03228069 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood drawn after rabies booster vaccination
Description: Blood would be drawn for testing of rabies neutralizing antibody titers, rabies specific T lymphocytes and regulatory T cells after receipt of rabies booster vaccination at least a year before.
Study NCT04170790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saxagliptin 5mg
Description: Saxagliptin 5mg oral tablet
Study NCT04170790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Description: Sildenafil 50 mg Oral Tablet
Study NCT01200238 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STA-9090
Study NCT00482443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A software programme in mobile telephone
Description: Use of Mobile phone technology in maintaining Diabetes Interactive Diary.
Study NCT00482443 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Education Programme.
Description: Control Arm patients will receive a standard education programme designed to help the Type 1 Diabetic manage their condition.
Study NCT04295616 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Description: IPV is a well-tolerated method to pump air jets into the lungs via a mouth mask at frequencies of 100-400 pulses per minute.~Each IPV session lasts 15 minutes, whereby the person with MS is firstly administered with a mask for 3 minutes at a high frequency (250 to 400 cycles per minute) and then 12 minutes with a low frequency (75 to 150 cycles per minute). The pressure (1.1 - 1.4 bar) is adjusted so that it is comfortable for every participant, yet there is the maximum possible expansion of the thorax. The sessions are given by speech therapists who are familiar with IPV. The IPV treatment will be provided 5 days a week, during 3 or 4 weeks.
Study NCT04295616 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active breathing training
Description: The active breathing exercises are based on the flow-based incentive spirometer (Inspirix). The Inspirix is a device consisting of a tube with a ball. A plastic tube is connected to the device with a mouthpiece in which the person with MS will has to breathe in and out. The device is equipped with a control button to build up the resistance (number of cc / sec). The aim is to train the inspiratory and expiratory volume as well as the inspiratory and expiratory exhalation force. These exercises are offered 5 times a week in groups under the supervision of an experienced speech therapist, during 3 or 4 weeks.
Study NCT04295616 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active breathing training
Description: The active breathing exercises are based on the flow-based incentive spirometer (Inspirix). The Inspirix is a device consisting of a tube with a ball. A plastic tube is connected to the device with a mouthpiece in which the person with MS will has to breathe in and out. The device is equipped with a control button to build up the resistance (number of cc / sec). The aim is to train the inspiratory and expiratory volume as well as the inspiratory and expiratory exhalation force. These exercises are offered 5 times a week in groups under the supervision of an experienced speech therapist, during 3 or 4 weeks.
Study NCT03171727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: low molecular weight heparin
Description: After TIPS procedure was performed, low molecular weight heparin was given for three days.
Study NCT01028326 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PCV10 and DTaP
Description: A nurse will administer a 0.5mL intramuscular dose of PCV10 on day 0 and day 60 and a 0.5 mL intramuscular dose of DTaP on day 180.